U.S., May 5 -- ClinicalTrials.gov registry received information related to the study (NCT07564726) titled 'Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High Cholesterol' on April 27.
Brief Summary: The goal of this clinical trial is to test whether one pill that combines ezetimibe, rosuvastatin, and amlodipine can safely lower cholesterol and blood pressure in Korean adults with high blood pressure and high cholesterol.
Study Start Date: Aug. 05, 2022
Study Type: INTERVENTIONAL
Condition:
Hypertension
Hypercholesterolemia
Intervention:
DRUG: Amlodipine
Oral tablet containing amlodipine 10 mg administered for 8 weeks.
DRUG: Ezetimibe/Rosuvastatin
Fixed-dose combination oral tabl...